Fredun Pharmaceuticals Ltd
NSE: BSE: 539730
₹1678.55
(-0.73%)
Sun, 15 Mar 2026, 07:14 am
Market Cap9.07B
PE Ratio24.25
Dividend0.04
Fredun Pharmaceuticals Financials
| Particulars | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 422.69M | 566.02M | 580.67M | 968.98M | 1.13B | 1.34B | 2.22B | 2.73B | 3.48B | 4.54B |
| Gross profit | 79.79M | 90.70M | 93.53M | 226.30M | 148.72M | 161.12M | 256.20M | 413.94M | 574.90M | 799.67M |
| Operating expenses (excl. COGS) | -45.95M | -63.04M | -60.57M | -135.76M | -84.09M | -87.23M | -138.91M | -162.16M | -231.07M | -311.85M |
| Selling/general/admin expenses, total | -42.41M | -63.43M | -59.96M | -133.68M | -82.63M | -84.12M | -136.08M | -150.47M | -208.51M | -257.59M |
| Research & development | 0 | — | -1.70M | -5.54M | -6.49M | -5.39M | -7.32M | -8.37M | -13.42M | -20.93M |
| Selling/general/admin expenses, other | -42.41M | -63.43M | -58.26M | -128.14M | -76.14M | -78.73M | -128.77M | -142.09M | -195.10M | -236.66M |
| Other operating expenses, total | -3.54M | 389.61K | -614.19K | -2.08M | -1.45M | -3.11M | -2.83M | -11.70M | -22.56M | -54.26M |
| Operating income | 33.85M | 27.66M | 32.96M | 90.54M | 64.64M | 73.88M | 117.29M | 251.78M | 343.83M | 487.82M |
| Non-operating income, total | -15.50M | -5.40M | -6.54M | -28.92M | -40.71M | -41.82M | -31.29M | -76.69M | -129.31M | -212.88M |
| Interest expense, net of interest capitalized | -20.59M | -18.75M | -19.41M | -30.96M | -44.14M | -41.62M | -46.69M | -92.83M | -136.50M | -223.77M |
| Interest capitalized | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-operating income, excl. interest expenses | 2.19M | 6.10M | 12.86M | 2.04M | 4.45M | 1.49M | 15.54M | 15.34M | 7.19M | 20.11M |
| Non-operating interest income | 168.05K | 267.88K | 400.72K | 494.55K | 677.02K | 226.69K | 55.00K | 227.00K | 137.00K | 1.10M |
| Miscellaneous non-operating expense | 2.02M | 5.83M | 12.46M | 1.54M | 3.77M | 1.26M | 15.49M | 15.11M | 7.05M | 19.01M |
| Unusual income/expense | 2.91M | 7.24M | 0 | — | -1.01M | -1.69M | -150.00K | 799.00K | 0 | -9.23M |
| Pretax income | 18.35M | 22.26M | 26.42M | 61.62M | 24.95M | 32.07M | 86.00M | 175.09M | 214.52M | 274.94M |
| Taxes | -7.66M | -7.99M | -8.91M | -17.02M | -5.93M | -11.92M | -22.65M | -67.02M | -58.28M | -77.54M |
| Non-controlling/minority interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| After tax other income/expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income before discontinued operations | 10.69M | 14.27M | 17.51M | 44.60M | 19.02M | 20.15M | 63.35M | 108.07M | 156.23M | 197.39M |
| Net income | 10.69M | 14.27M | 17.51M | 44.60M | 19.02M | 20.15M | 63.35M | 108.07M | 156.23M | 197.39M |
| Dilution adjustment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Preferred dividends | — | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted net income available to common stockholders | 10.69M | 14.27M | 17.51M | 44.60M | 19.02M | 20.15M | 63.35M | 108.07M | 156.23M | 197.39M |
| Basic earnings per share (Basic EPS) | - | - | - | - | - | - | - | - | - | - |
| Diluted earnings per share (Diluted EPS) | - | - | - | - | - | - | - | - | - | - |
| EBITDA | 41.89M | 39.02M | 45.81M | 103.84M | 83.43M | 93.92M | 138.86M | 279.87M | 381.79M | 538.21M |
| EBIT | 33.85M | 27.66M | 32.96M | 90.54M | 64.64M | 73.88M | 117.29M | 251.78M | 343.83M | 487.82M |
| Total operating expenses | -388.84M | -538.35M | -547.71M | -878.43M | -1.06B | -1.26B | -2.10B | -2.48B | -3.14B | -4.05B |
| Prepaid expenses | 2.15M | 3.56M | 1.58M | — | — | — | — | — | — | — |
| Deferred income, current | 26.78M | 18.01M | 10.17M | — | 62.80M | 51.38M | 9.12M | 11.25M | 16.92M | 86.23M |
| Capital and operating lease obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating lease liabilities | — | — | — | — | — | — | — | — | — | — |
| Deferred tax liabilities | 6.90M | 8.48M | 8.09M | 7.92M | 9.41M | 13.77M | 14.31M | 38.43M | 41.37M | 44.84M |
| Deferred income, non-current | — | — | — | — | — | — | — | — | — | — |
| Minority interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in accrued expenses | — | — | — | — | — | — | — | — | — | — |
| Common dividends paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Preferred dividends paid | — | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Open Your Free Demat Account Now!
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800